IPO Listed — 30 Dec 2025
Listing Price: ₹120
Gujarat Kidney & Super Speciality IPO GMP History | Listing Price ₹120 & Kostak Rate
Gujarat Kidney & Super Speciality IPO has been listed on December 30, 2025 at a listing price of ₹120, against the issue price of ₹114 — a gain of ₹6 (+5.26%). The GMP peaked at ₹55 on 4 January 2026 and reached a low of ₹55 on 4 January 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Gujarat Kidney & Super Speciality IPO raised ₹250.80 Cr. through its IPO at a price band of ₹108 to 114 per share, with a lot size of 128 shares. The IPO was open for subscription from 22 Dec 2025 to 24 Dec 2025.
Table of Contents
- Gujarat Kidney & Super Speciality IPO GMP Today
- Gujarat Kidney & Super Speciality IPO GMP Trend History
- Gujarat Kidney & Super Speciality IPO Dates
- Actual Listing Price
- Is Gujarat Kidney & Super Speciality IPO GMP Reliable?
- Kostak Rate Explained
- About Gujarat Kidney & Super Speciality IPO
- Frequently Asked Questions
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 04 Jan 2026 | ₹ 55 | 10%% | ₹ 0 | ₹ 0 |
Gujarat Kidney & Super Speciality IPO Dates
| Event | Date |
|---|---|
| Open Date | 22 Dec, 2025 |
| Close Date | 24 Dec, 2025 |
| Allotment Date | 26 Dec, 2025 |
| Refund Date | 29 Dec, 2025 |
| Credit to Demat | 29 Dec, 2025 |
| Listing Date | 30 Dec, 2025 |
Gujarat Kidney & Super Speciality IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹114 |
| GMP-Based Estimate (Pre-Listing) | ₹163 (+50.9%) |
| Actual Listing Price | ₹120 (+5.26%) |
| Listing Gain / Loss | +₹6 per share |
| Listing Date | 30 Dec, 2025 |
Is Gujarat Kidney & Super Speciality IPO GMP Reliable?
Grey market premium for Gujarat Kidney & Super Speciality IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Gujarat Kidney & Super Speciality IPO full review for a fundamentals-based assessment before making any grey market trades.
Gujarat Kidney & Super Speciality IPO IPO Kostak Rate Explained
The Kostak rate for Gujarat Kidney & Super Speciality IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Gujarat Kidney & Super Speciality IPO
The hospital offers a wide range of services including nephrology, urology, cardiology, intensive care, and other super speciality treatments. It is equipped with advanced dialysis units, operation theatres, and diagnostic facilities to support comprehensive patient care. The business model is primarily service-driven, generating revenue through consultations, procedures, diagnostic services, and inpatient care. By maintaining a balance between affordability and quality, the hospital aims to serve both urban and semi-urban populations while building long-term trust and relationships with patients.
Frequently Asked Questions about Gujarat Kidney & Super Speciality IPO
What is the GMP of Gujarat Kidney & Super Speciality IPO?
The current Grey Market Premium (GMP) of Gujarat Kidney & Super Speciality IPO is ₹ 55.
What is the Kostak Price of Gujarat Kidney & Super Speciality IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Gujarat Kidney & Super Speciality IPO is currently not available.
What is the Subject to Sauda Price of Gujarat Kidney & Super Speciality IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.
What was the actual listing price of Gujarat Kidney & Super Speciality IPO?
Gujarat Kidney & Super Speciality IPO listed on December 30, 2025 at ₹120, against the issue price of ₹114 — a gain of +5.26%.
How did the GMP of Gujarat Kidney & Super Speciality IPO trend before listing?
The GMP of Gujarat Kidney & Super Speciality IPO was stable in its final days before listing. The GMP peaked at ₹55 on 4 January 2026. View the day-wise table above for the complete GMP history.
Explore Gujarat Kidney & Super Speciality IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!